Envista Stock (NYSE:NVST)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$18.03

52W Range

$15.14 - $25.64

50D Avg

$20.03

200D Avg

$18.90

Market Cap

$3.22B

Avg Vol (3M)

$2.01M

Beta

1.31

Div Yield

-

NVST Company Profile


Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The firm operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. Its Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.

Show More

Industry

Medical - Equipment & Services

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

12,800

IPO Date

Sep 18, 2019

Website

NVST Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 23Dec 22Dec 21
Equipment and Consumables$924.10M--
Specialty Products and Technologies$1.64B--
Consumables-$2.15B$2.07B
Equipment Sales-$421.60M$441.00M

Fiscal year ends in Dec 23 | Currency in USD

NVST Financial Summary


Dec 23Dec 22Dec 21
Revenue$2.57B$2.57B$2.51B
Operating Income$31.50M$319.20M$306.20M
Net Income$-100.20M$243.10M$263.50M
EBITDA$429.40M$484.40M$460.50M
Basic EPS$-0.60$1.51$1.63
Diluted EPS$-0.60$1.37$1.48

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q3 24Oct 30, 24 | 9:44 PM
Q2 24Aug 07, 24 | 10:35 PM
Q1 24May 01, 24 | 12:00 AM

Peer Comparison


TickerCompany
MMSIMerit Medical Systems, Inc.
ATRCAtriCure, Inc.
ALCAlcon Inc.
RMDResMed Inc.
ANGOAngioDynamics, Inc.
HAEHaemonetics Corporation
COOThe Cooper Companies, Inc.
WSTWest Pharmaceutical Services, Inc.
AKYAAkoya Biosciences, Inc.
HOLXHologic, Inc.
ICUIICU Medical, Inc.
ATRAptarGroup, Inc.
TFXTeleflex Incorporated